Abnormalities in body composition can occur at any body weight. Low muscle mass is a
predictor of poor morbidity and mortality and occurs in several populations. This narrative …

In addition to facilitating healthcare delivery planning, reliable information about prognosis is
essential for treatment decisions in patients with idiopathic pulmonary fibrosis (IPF). This …

Background Few data are available on the long-term effect of pulmonary rehabilitation (PR)
and on long PR programs in interstitial lung diseases (ILD). We aimed to evaluate the effects …

Variable patterns of disease progression are typically observed in patients with idiopathic
pulmonary fibrosis (IPF). We sought to determine the prognostic capacity of blood cell count …

Background Nintedanib is an approved therapy for idiopathic pulmonary fibrosis (IPF). Some
patients treated with nintedanib experience weight loss. Exploratory data suggest that low …

Interstitial lung disease (ILD) is a diverse group of inflammatory and fibrotic lung conditions
causing significant morbidity and mortality. A multitude of factors beyond the lungs influence …

Introduction and aims Malnutrition is frequent in patients with idiopathic pulmonary fibrosis
(IPF). We examined the relationship between malnutrition at diagnosis and all-cause …

While high-level evidence is lacking, numerous retrospective studies have depicted the
value of supplemental oxygen in idiopathic pulmonary fibrosis (IPF) and other interstitial …

In idiopathic pulmonary fibrosis (IPF), several factors may have a negative impact on the
nutritional status, including an increased respiratory muscles load, release of inflammation …

Background Nutritional status impacts quality of life and prognosis of patients with
respiratory diseases, including idiopathic pulmonary fibrosis (IPF). However, there is a lack …